DMAAU
Drugs Made In America Acquisition Corp. UnitsNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$308.64M
P/E Ratio
—
EPS
—
Beta
—
52W High
$10.60
52W Low
$10.19
50-Day MA
$10.53
200-Day MA
$10.52
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Drugs Made In America Acquisition Corp. Units
Drugs Made In America Acquisition Corp. Units (DMAAU) is a special purpose acquisition company (SPAC) dedicated to merging with pioneering companies in the pharmaceutical and healthcare industries. Backed by a seasoned management team with deep sector expertise, DMAAU aims to drive transformative growth and enhance the accessibility of medicines in the U.S. As the focus on domestic drug manufacturing intensifies, DMAAU presents a strategic opportunity for institutional investors looking to participate in the evolving landscape of health technology and the pharmaceutical sector's shift toward innovation and affordability.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.46% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.21 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $29.17M |
| Float | $27.31M |
| % Insiders | 17.88% |
| % Institutions | 2.60% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
5.72%
HV 30-Day
4.64%
HV 60-Day
3.41%
HV Rank
44.0%
Volatility is currently contracting
Data last updated: 5/1/2026